Rx risk communication meeting
Executive Summary
FDA public meeting to seek input on the agency's risk communication mechanisms is slated for Dec. 7-8. Discussion topics include patient information sheets, health care professional sheets, talk papers, public health advisories, CDER's educational campaigns and website. The meeting will be held at the National Transportation Safety Board boardroom and conference center in Washington, D.C. (1"The Pink Sheet" Sept. 19, 2005, p. 18)...